To furnish direct proof that the peculiar improvement of catecholaminergic activity in the brain in animals treated with a small dose of (?)deprenyl is unrelated to MAO inhibition, we designed inside the early '90s a relatives of deprenyl analogues devoid from the MAO-B inhibitory effect (Knoll et alBy means of PPAP, suppliers and clients concur up